DISCLOSURE DIGEST
US insider purchases disclosed in week 2026-W32
2026-08-03 to 2026-08-09. 256 purchase disclosures at 138 companies by 222 buyers; reported value $629.4M.
- purchase disclosures
- 256
- companies
- 138
- buyers
- 222
- reported value
- $629.4M
Largest reported purchases by company
| Company | Ticker | Buyers | Disclosures | Reported value |
|---|---|---|---|---|
| Braveheart Bio, Inc. | BRVE | 10 | 10 | $263.8M |
| AppTech Payments Corp. | APCX | 1 | 3 | $115.9M |
| Attovia Therapeutics, Inc. | ATTO | 7 | 7 | $65.7M |
| B&R Technology Merger Corp. | BRTMU | 5 | 5 | $34.4M |
| East West Ave Acquisition Corp. | EWAV | 2 | 2 | $21.7M |
| Churchill Capital Corp XIII | XIIIU | 3 | 3 | $10.5M |
| MA Specialty Credit Income Fund | SCISX | 1 | 1 | $10.0M |
| Privacore VPC Asset Backed Credit Fund | NONE | 4 | 4 | $10.0M |
| 2023 ETF Series Trust | NFRX | 1 | 1 | $10.0M |
| John Hancock GA Mortgage Trust | 3 | 3 | $10.0M | |
| BOSTON SCIENTIFIC CORP | BSX | 3 | 4 | $9.4M |
| 51Talk Online Education Group | COE | 1 | 1 | $8.1M |
| Apnimed, Inc. | APMD | 2 | 2 | $5.2M |
| Aptiv PLC | APTV | 1 | 1 | $5.0M |
| PEOPLES FINANCIAL CORP /MS/ | PFBX | 5 | 5 | $4.7M |
| DISCIPLINED GROWTH ACQUISITION Corp | DGAC | 2 | 2 | $3.6M |
| NextCure, Inc. | NXTC | 2 | 2 | $3.0M |
| GBank Financial Holdings Inc. | GBFH | 9 | 9 | $2.8M |
| COSTAR GROUP, INC. | CSGP | 1 | 1 | $2.5M |
| Goosehead Insurance, Inc. | GSHD | 2 | 2 | $2.3M |
| PFIZER INC | PFE | 2 | 2 | $2.0M |
| American Bitcoin Corp. | ABTC | 1 | 1 | $1.9M |
| TOYOTA MOTOR CORP/ | TM | 1 | 1 | $1.6M |
| CARVANA CO. | CVNA | 1 | 1 | $1.5M |
| GRAN TIERRA ENERGY INC. | GTE | 3 | 3 | $1.2M |
Companies with two or more buyers
| Company | Ticker | Buyers | Disclosures | Reported value |
|---|---|---|---|---|
| Braveheart Bio, Inc. | BRVE | 10 | 10 | $263.8M |
| GBank Financial Holdings Inc. | GBFH | 9 | 9 | $2.8M |
| Attovia Therapeutics, Inc. | ATTO | 7 | 7 | $65.7M |
| Jersey Mike's Subs Inc. | JMKE | 6 | 6 | $1.0M |
| OKYO Pharma Ltd | OKYO | 6 | 7 | $136.0k |
| B&R Technology Merger Corp. | BRTMU | 5 | 5 | $34.4M |
| PEOPLES FINANCIAL CORP /MS/ | PFBX | 5 | 5 | $4.7M |
| Privacore VPC Asset Backed Credit Fund | NONE | 4 | 4 | $10.0M |
| Orion Group Holdings Inc | ORN | 4 | 4 | $320.8k |
| Camp4 Therapeutics Corp | CAMP | 4 | 4 | $59.5k |
| JEWETT CAMERON TRADING CO LTD | JCTC | 4 | 4 | $39.5k |
| FIRST UNITED CORP/MD/ | FUNC | 4 | 4 | $12.8k |
| Churchill Capital Corp XIII | XIIIU | 3 | 3 | $10.5M |
| John Hancock GA Mortgage Trust | 3 | 3 | $10.0M | |
| BOSTON SCIENTIFIC CORP | BSX | 3 | 4 | $9.4M |
| GRAN TIERRA ENERGY INC. | GTE | 3 | 3 | $1.2M |
| COASTAL FINANCIAL CORP | CCB | 3 | 3 | $1.1M |
| TRACTOR SUPPLY CO /DE/ | TSCO | 3 | 3 | $652.4k |
| BED BATH & BEYOND, INC. | BBBY | 3 | 3 | $307.5k |
| MacKenzie Realty Capital, Inc. | MKZR | 3 | 3 | $262.8k |
| Tilray Brands, Inc. | TLRY | 3 | 3 | $69.2k |
| East West Ave Acquisition Corp. | EWAV | 2 | 2 | $21.7M |
| Apnimed, Inc. | APMD | 2 | 2 | $5.2M |
| DISCIPLINED GROWTH ACQUISITION Corp | DGAC | 2 | 2 | $3.6M |
| NextCure, Inc. | NXTC | 2 | 2 | $3.0M |
By buyer role
| Buyer role | companies | Disclosures | Reported value |
|---|---|---|---|
| 10% Owner | 30 | 73 | $424.2M |
| Director | 58 | 78 | $145.0M |
| Chief Executive Officer | 31 | 34 | $29.4M |
| Other | 5 | 9 | $12.1M |
| Officer | 11 | 14 | $7.3M |
| See Remarks | 4 | 5 | $4.3M |
| President | 11 | 12 | $3.7M |
| Chief Financial Officer | 16 | 16 | $1.8M |
| Executive Chairman | 1 | 1 | $816.8k |
| EVP & GM, EES | 1 | 1 | $351.3k |
| SECRETARY | 1 | 1 | $105.3k |
| Treasurer | 1 | 1 | $87.6k |
| General Counsel/Secretary | 1 | 1 | $87.6k |
| VP | 1 | 1 | $73.1k |
| EVP, Head of Comm Banking | 1 | 1 | $59.7k |
| EVP & GENERAL COUNSEL | 1 | 1 | $49.0k |
| Executive Chair | 1 | 1 | $13.1k |
| Global General Counsel | 1 | 1 | $11.1k |
| SVP, Gen Counsel & Secretary | 1 | 1 | $8.1k |
| EXEC. CHAIR & PRINCIPAL OFF. | 1 | 1 | $4.7k |
| EXEC. CHAIR & PRINCIPAL OFF | 1 | 1 | $1.3k |
| Senior VP and Secretary | 1 | 1 | $200 |
| VP, Human Resources | 1 | 1 | $100 |
Purchases are Form 4 open-market purchases (code P) of qualifying equity as classified by the site's US screening rules; grants, option exercises, gifts and derivatives are excluded. Values are as reported, in USD. No score or rank is used on this page.